| Title | Author(s) | Year | View Count |  | Prevalence and time trend of intestinal metaplasia in Hong Kong | Yee, YK; Wong, KW; Hui, CK; Chan, CK; Chan, AOO; Lam, SK; Fung, FMY; Hung, I; Wong, BCY | 2009 | 165 |
| Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection | Wong, WM; Gu, Q; Chu, KM; Yee, YK; Fung, FMY; Tong, TSM; Chan, AOO; Lai, KC; Chan, CK; Wong, BCY | 2006 | 86 |
| Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy | Gu, Q; Xia, HHX; Wang, JD; Wong, WM; Chan, AOO; Lai, KC; Chan, CK; Yuen, MF; Fung, FMY; Wong, KW; Lam, SK; Wong, BCY | 2006 | 123 |
 | Lansoprazole, levofloxacin and amoxicillin triple therapy versus quadruple therapy as second-line treatment of resistant Helicobacter pylori infection | Wong, WMR; Gu, Q; Chu, KM; Yee, YK; Fung, FMY; Tong, SM; Chan, OOA; Lai, KC; Chan, CK; Wong, BCY | 2006 | 136 |
| Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients | Wong, WM; Huang, J; Xia, HHX; Fung, FMY; Tong, TSM; Cheung, KL; Ho, VYK; Lai, KC; Chan, CK; Chan, AOO; Hui, CK; Lam, SK; Wong, BCY | 2005 | 117 |
| Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong | Xia, B; Xia, HHX; Ma, CW; Wong, KW; Fung, FMY; Hui, CK; Chan, CK; Chan, AOO; Lai, KC; Yuen, MF; Wong, BCY | 2005 | 257 |
| Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy. | Gu, Q; Xia, HHX; Wang, J; Chan, OO; Lai, KC; Fung, FMY; Wong, KW; Cheung, KL; Kung, H; Wong, BCY | 2005 | 100 |
| Natural acquisition of Helicobacter pylori in adult dyspeptic patients with or without previous infection – a 7-year follow-up study.
Australian Gastroenterology Week 2005, 19 October 2005, Australia. | Xia, HHX; Wong, RWM; Chan, OO; Lam, SK; Lai, KC; Chan, CK; Cheung, KL; Fung, FMY; Wong, KW; Wong, BCY | 2005 | 81 |
 | Randomised controlled study of rabeprazole, levofloxacin and rifabutin triple therapy versus quadruple therapy as second-line treatment of Helicobacter pylori infection | Wong, WM; Gu, Q; Lam, SK; Fung, FMY; Lai, KC; Hu, WHC; Yee, YK; Chan, CK; Xia, HHX; Yuen, MF; Wong, BCY | 2003 | 221 |
| Effects of Primary Metronidazole and Clarithromycin Resistance to Helicobacter pylori on Omeprazole, Metronidazole, and Clarithromycin Triple-Therapy Regimen in a Region with High Rates of Metronidazole Resistance | Wong, WM; Gu, Q; Wang, WH; Fung, FMY; Berg, DE; Lai, KC; Xia, HHX; Hu, WHC; Chan, CK; Chan, AOO; Yuen, MF; Hui, CK; Lam, SK; Wong, BCY | 2003 | 450 |
| Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection | Wong, WM; Gu, O; Lam, SK; Fung, FMY; Lai, KC; Hu, WHC; Yee, YK; Chan, CK; Xia, HHX; Yuen, MF; Wong, BCY | 2003 | 78 |
| One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese | Hung, WK; Wong, WM; Wong, GSW; Yip, AWC; Szeto, ML; Lai, KC; Hu, WHC; Chan, CK; Xia, HHX; Yuen, MF; Fung, FMY; Tong, TSM; Ho, VYK; Lam, SK; Wong, BCY | 2002 | 170 |
| Evaluation of three near patient tests for the diagnosis of Helicobacter pylori (H. pylori) infection in Chinese population | Wong, WM; Wong, BCY; Tang, VSY; Wong, KW; Li, TM; Cheung, KL; Fung, FMY; Lai, KC; Hu, WHC; Chan, CK; Xia, HHX; Lam, SK | 2002 | 211 |
| Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients | Wong, WM; Wong, BCY; Hung, WK; Yee, YK; Yip, AWC; Szeto, ML; Fung, FMY; Tong, TSM; Lai, KC; Hu, WHC; Yuen, MF; Lam, SK | 2002 | 323 |
| One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies | Wong, WM; Wong, BCY; Lu, H; Gu, Q; Yin, Y; Wang, WH; Fung, FMY; Lai, KC; Xia, HHX; Xiao, SD; Lam, SK | 2002 | 117 |
| Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese population | Xia, HHX; Wong, BCY; Wong, WM; Tang, VSY; Cheung, HKL; Sham, FNF; Fung, FMY; Lai, KC; Hu, WHC; Chan, CK; Lam, SK | 2002 | 96 |
| One week omeprazole, furazolidone and amoxycillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies | Gu, Q; Wong, WM; Lam, SK; Yin, Y; Wang, WH; Fung, FMY; Lai, KC; Xia, HHX; Wong, BCY; Xiao, SD | 2002 | 88 |
| Randomized controlled trial of rabeprazole, levofloxacin and rifabutin triple therapy versus rabeprazole-based quadruple therapy as a rescue treatment for failure of Helicobacter pylori eradication with standard tiple therapies | Wong, WM; Gu, Q; Lam, SK; Fung, FMY; Lai, KC; Xia, HHX; Hu, HC; Wong, BCY | 2002 | 87 |
| Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: A randomized controlled study | Wong, BCY; Wang, WH; Wong, WM; Lau, GKK; Fung, FMY; Kung, NNS; Chu, KM; Lai, KC; Hu, WHC; Hu, FL; Liu, XG; Chan, CK; Yuen, MF; Hui, WM; Lam, SK | 2001 | 104 |
| High prevalence of mixed infections by Helicobacter pylori in Hong Kong: Metronidazole sensitivity and overall genotype | Wong, BCY; Wang, WH; Berg, DE; Fung, FMY; Wong, KW; Wong, WM; Lai, KC; Cho, CH; Hui, WM; Lam, SK | 2001 | 334 |
|
